ClinConnect ClinConnect Logo
Search / Trial NCT03606603

Nutrition Insights Day Asia

Launched by FRESENIUS KABI · Jul 23, 2018

Trial Information

Current as of April 25, 2025

Completed

Keywords

Nutritional Status Malnutrition Energy Intake Protein Intake Icu Surgical Ward Hospital Enteral Nutrition Parenteral Nutrition Nutrition

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patients after elective major abdominal gastrointestinal surgery \[i.e. elective major GI resections, partial or total, especially for cancer, including: esophagectomy, gastrectomy, enterectomy (small bowel resection), colectomy, hepatectomy, pancreatectomy, resections for gall bladder or bile duct cancer (cholangiocarcinoma)\] with pre-existing malnutrition or who are at significant risk for malnutrition or nutrition-related complications\*, with indications for nutritional support
  • 2. Hospitalization on SICU or major surgical ward on the NID
  • 3. Use of EN (nutritional intake provided via tube feeding) and/or PN for at least one day before the NID
  • 4. If patient received oral nutrition (ON) or oral nutrition supplements (ONS) during the observational phase from day -5 to day -2, complete and reliable data of daily caloric and protein intake is available
  • 5. Latest surgical intervention ≤ 10 days before NID
  • Exclusion Criteria:
  • 1. Patients with burn injuries
  • 2. Patients requiring postsurgical mechanical ventilation and sedation on the NID
  • 3. Patients receiving ON and/or ONS at any quantity on the day before the NID
  • 4. Patients requiring emergency procedures

Trial Officials

John F Stover, M.D.

Study Chair

Fresenius Kabi

About Fresenius Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technology, with a strong focus on the areas of intravenous (IV) therapies, infusion devices, and clinical nutrition. With a commitment to enhancing patient care, Fresenius Kabi conducts innovative clinical trials to develop high-quality pharmaceuticals and medical devices that address unmet medical needs. The company leverages its extensive expertise in drug formulation and delivery systems to advance therapeutic solutions across various clinical indications, ensuring safety and efficacy in diverse patient populations. Through its robust research and development initiatives, Fresenius Kabi aims to contribute significantly to the healthcare landscape and improve outcomes for patients worldwide.

Locations

Ho Chi Minh City, , Vietnam

Seoul, , Korea, Republic Of

Taipei, , Taiwan

Pune, , India

Taipei, , Taiwan

Manila, , Philippines

Bangkok, , Thailand

Bangkok, , Thailand

Linkou, , Taiwan

Daegu, , Korea, Republic Of

Taichung, , Taiwan

Hyderabad, , India

Quezon City, , Philippines

Seoul, , Korea, Republic Of

Bangalore, , India

Bangkok, , Thailand

Cebu City, , Philippines

Pasig City, , Philippines

Quezon City, , Philippines

Quezon City, , Philippines

Bangkok, , Thailand

Bangkok, , Thailand

Pune, , India

Chennai, , India

Secunderabad, , India

Taichung, , Taiwan

Kaohsiung, , Taiwan

Seoul, , Korea, Republic Of

Kaohsiung, , Taiwan

Chungnam, , Korea, Republic Of

Seoul, , Korea, Republic Of

Manila, , Philippines

Manila, , Philippines

Coimbatore, , India

Daegu, , Korea, Republic Of

Makati City, , Philippines

Surin, , Thailand

Hanoi, , Vietnam

Cebu City, , Philippines

Goyang Si, , Korea, Republic Of

Mohali, , India

Chang Hua, , Taiwan

Chiang Mai, , Thailand

Ho Chi Minh City, , Vietnam

Vellore, , India

Hanoi, , Vietnam

Davao City, , Philippines

Jakarta, , Indonesia

Bombay, , India

Chennai, , India

Dehli, , India

Dehli, , India

Dhakuria, , India

Gurgaon, , India

Gurgaon, , India

Jaipur, , India

Jaipur, , India

Kolkata, , India

Ludhiana, , India

Mohali, , India

Mumbai, , India

Mumbai, , India

New Delhi, , India

Puducherry, , India

Sūrat, , India

Udaipur, , India

Jakarta, , Indonesia

Jakarta, , Indonesia

Jeruk, , Indonesia

Semarang, , Indonesia

Semarang, , Indonesia

Waru, , Indonesia

Yogyakarta, , Indonesia

Yogyakarta, , Indonesia

Seoul, , Korea, Republic Of

Ulsan, , Korea, Republic Of

Cagayan De Oro, , Philippines

Dasmariñas, , Philippines

Manila, , Philippines

Manila, , Philippines

Manila, , Philippines

Quezon City, , Philippines

San Fernando, , Philippines

Kaohsiung City, , Taiwan

Bangkok, , Thailand

Bangkok, , Thailand

Hat Yai, , Thailand

Phuket, , Thailand

Ho Chi Minh City, , Vietnam

Ho Chi Minh City, , Vietnam

Huế, , Vietnam

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials